Regeneron and Sanofi declare plans to make Praluent more accessible for patients at high risk Read more
Abbott’s HeartMate 3 Heart Pump displays enhanced survival and lower rates of Stroke and Pump Thrombosis Read more
Janssen Pharmaceutical’s INVOKANA alleviates risk of CV death or HHF in type 2 diabetes patients Read more